IMPORTANT DATES

  • Registration: NOW OPEN
  • Exhibit booth sales: NOW OPEN
  • Late-breaker Abstract submission site: CLOSED
  • Early bird registration deadline: April 20, 2017
  • Hotel reservation deadline: May 17, 2017

MEETING LOCATION

Ernest N. Morial Convention Center
900 Convention Center Blvd.
New Orleans, LA 70130
www.mccno.com

"The experience for me as a new tech attending the first ASM Microbe conference was very informative and enjoyable."
Tyrell Cox, Medical Lab Scientist, BUMCT

General Sessions

Opening Session
Future of ASM and President's Forum
Keynote Address

June 1, 2017
5:00 p.m. - 6:45 p.m.

Opening Session 

Conveners:
Nicole Dubilier; Program Committee Co-chair; Max Planck Inst. of Marine Microbiol., Bremen, Germany
Robin Patel; Program Committee Co-chair; Mayo Clinic, Rochester, MN

Welcome:
Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR

ASM CEO Introductory Remarks: 
Stefano Bertuzzi; American Society for Microbiol., Washington, DC 

Speakers:
Julie Theriot; Stanford Univ., Stanford, CA

Lalita RamakrishnanLalita Ramakrishnan; Univ. of Cambridge, Cambridge, United Kingdom

Lalita Ramakrishnan is a professor of immunology and infectious diseases at the University of Cambridge in the United Kingdom. Prior to her current position, she served as an Attending Physician for Infectious Diseases Consultation at the University of Washington Hospital. She has received more than 10 honors and awards, including appointment to the U.S. National Academy of Sciences in 2015. Additionally, she has been a reviewer for more than 25 journals including Cell, Molecular Cell, Nature, Science, Nature Medicine, Nature Immunology, Immunity, Cell Host and Microbe, Cell Reports, Science Translational Medicine and PNAS. 

 

Nick LaneNick Lane; Univ. Coll. London, London, United Kingdom

Dr. Nick Lane is a professor of evolutionary biochemistry in the Department of Genetics, Evolution and Environment at University College London. His research is on bioenergetic constraints on cell structure and evolution. Dr. Lane is Co-Director of the new Centre for Life’s Origins and Evolution (CLOE) at UCL and was a founding member of the UCL Consortium for Mitochondrial Research. His work has been recognized by several awards, including the Biochemical Society Award in 2015 and the Royal Society Michael Faraday Prize in 2016. He has published some 80 research papers and articles, co-edited two volumes and written four celebrated books for the general public, which have been translated into 25 languages – Oxygen (OUP, 2002), Power, Sex, Suicide (OUP, 2005), Life Ascending (WW Norton 2009) and The Vital Question (WW Norton, 2015). Life Ascending won the Royal Society Prize for Science Books in 2010, while Bill Gates described The Vital Question as “an amazing inquiry into the origins of life."


June 2, 2017
11:00 a.m. - 12:30 p.m.

Future of ASM and President's Forum

Convener: 
Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR

Future of ASM
Susan E. Sharp; Kaiser Permanente - Northwest, Portland, OR
Stefano Bertuzzi; American Society for Microbiol., Washington, DC

President's Forum

Heidi NelsonHeidi Nelson; Mayo Clinic, Rochester, MN

Heidi Nelson, MD, is the the Program Director of the Mayo Clinic Center for Individualized Medicine (CIM) Microbiome Program and Chair of the Department of Surgery. As leader of the Mayo Microbiome Program, she has focused her work on ensuring that the program infrastructure provides comprehensive as well as reliable/reproducible methodologic platforms. Specifically, she recruited and worked with key scientists and laboratory personnel to develop and standardize microbiome methods from sample collection and sequencing to analytics and complex modeling. The program has properly equipped and resourced core facilities that can support everything from computational modeling to germ free experimentation and human clinical trials. Microbiome work fits with her long standing research interest in colorectal cancer. She serves as the national PI and NCI-grant PI for the NIH-funded colon cancer trial, for evaluating the role of laparoscopic surgery in colorectal cancer treatment. Leadership roles have included the Mayo Clinic Cancer Center and the NCI Cooperative Groups. Additionally, she has been Vice Chair of the North Central Cancer Treatment Group and Group Co-Chair of American College of Surgeons Oncology Group. She also has been faculty for the AACR/ASCO Methods in Clinical Cancer Research Workshop and a member and then chair of two NIH (NCI) study sections including, Subcommittee H (Cooperative Group Study Section), Clinical Oncology (CONC) as well as a member of the NCI Clinical Trials Advisory Committee. 

Christopher WoodsChristopher W. Woods; Duke Univ. Med. Ctr., Durham, NC

Dr. Woods is a professor in the Departments of Medicine and Pathology at Duke University, adjunct associate professor in Epidemiology at the University of North Carolina-Chapel Hill School of Public Health, and adjunct associate professor in the Emerging Infections Program at the Duke-National University of Singapore Graduate Medical School. He is Co-Director of the Hubert-Yeargan Center for Global Health, and Associate Director for Applied Genomics in the Duke Center for Applied Genomics & Precision Medicine (CAGPM). Dr. Woods is the Global Health lead for the Duke Tropical Conservation Initiative. Clinically, he is Chief of Infectious Diseases, and hospital epidemiologist for the Durham VA Medical Center. Dr. Woods is board-certified in internal medicine, infectious diseases, and medical microbiology.

Dr. Woods has co-authored over 140 peer-reviewed articles. His research focuses on development of novel diagnostic approaches to infectious disease and potential for interspecies transmission of pathogens. His genomic approach to harnessing the host response for diagnosis of infectious diseases has been called a paradigm shift in the field. He is particularly interested in augmenting medical microbiology capacity in the developing world and epidemiology of emerging and re-emerging infectious diseases.


June 3, 2017
6:15 p.m. - 7:15 p.m.

Keynote Address 
TBA 

 

 

 

 

 

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

94791